BeStock  
Stocks › Biotechnology › BCAX

Bicara Therapeutics BCAX

US equityMarket cap rank #3530Biotechnology
$8.44 −$0.68 (-7.46%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $8.44 0.00%
Open$8.83
Prev close$9.12
Day range$8.43 – $9.14
Volume814.5K
Market cap$560.31M
P/E (TTM)–
Dividend yield–

BCAX Stock News

Headlines matching Bicara Therapeutics or the BCAX ticker, most recent first.

  • JonesTrading Maintains Bicara Therapeutics(BCAX.US) With Buy Rating, Maintains Target Price $30Market news · 8 Sep 2026 · Direct mention
  • Stifel Maintains Bicara Therapeutics(BCAX.US) With Buy Rating, Cuts Target Price to $45 NegativeMarket news · 14 Aug 2026 · Direct mention
  • Mizuho Securities Reaffirms Their Hold Rating on Bicara Therapeutics Inc. (BCAX)TipRanks · 13 Aug 2026 · Direct mention
  • Wedbush Reaffirms Their Buy Rating on Bicara Therapeutics Inc. (BCAX)TipRanks · 13 Aug 2026 · Direct mention
  • Analysts Are Bullish on Top NA Stocks: Veradermics, Incorporated (MANE), Bicara Therapeutics Inc. (BCAX) PositiveTipRanks · 12 Aug 2026 · Direct mention
  • Morgan Stanley Maintains Bicara Therapeutics(BCAX.US) With Buy Rating, Maintains Target Price $37Market news · 12 Aug 2026 · Direct mention
  • Analysts Conflicted on These NA Names: Bicara Therapeutics Inc. (BCAX), CoreWeave (CRWV) and Cardinal Infrastructure Group, Inc. (CDNL)TipRanks · 12 Aug 2026 · Direct mention
  • BofA Securities Maintains Bicara Therapeutics(BCAX.US) With Buy Rating, Announces Target Price $34Market news · 12 Aug 2026 · Direct mention
  • BTIG Maintains Bicara Therapeutics(BCAX.US) With Buy Rating, Raises Target Price to $39 PositiveMarket news · 12 Aug 2026 · Direct mention
  • Analysts Offer Insights on NA Companies: Enhanced Group (ENHA), MNTN, Inc Class A (MNTN) and Bicara Therapeutics Inc. (BCAX)TipRanks · 12 Aug 2026 · Direct mention
  • Analysts Have Conflicting Sentiments on These NA Companies: Bending Spoons (BSP), EToro (ETOR) and Bicara Therapeutics Inc. (BCAX)TipRanks · 12 Aug 2026 · Direct mention
  • Analysts Offer Insights on NA Companies: Smithfield Foods (SFD), Bicara Therapeutics Inc. (BCAX) and Concentra Group Holdings Parent, Inc. (CON)TipRanks · 12 Aug 2026 · Direct mention
  • BTIG Maintains Bicara Therapeutics(BCAX.US) With Buy Rating, Maintains Target Price $28Market news · 28 Jul 2026 · Direct mention
  • Bicara Therapeutics Inc. (BCAX) Gets a Hold From Wells FargoTipRanks · 2 Jun 2026 · Direct mention
  • BofA Securities Maintains Bicara Therapeutics(BCAX.US) With Buy RatingMarket news · 2 Jun 2026 · Direct mention

Discussion

No comments yet — be the first to weigh in on BCAX.

Sign in to join the discussion.

Scroll to Top